Smart Medicine For Your Skin
There are now about 130 cannabinoids which have been discovered! Amazing! CBD is only one of many, but it is the predominant cannabinoid that we have discovered as of today. We are at the forefront of a whole new science, biochemistry, and industry and dermatology has it’s part too!
CBD or Cannabidiol extracts, which are produced directly from marijuana flowers, are up to 15 percent CBD (or 150,000 ppm).
CBD extracts can be produced indirectly from hemp manufacture as a by-product of the flowers and leaves that are mixed in with the stalks during hemp stalk processing for fiber. This has been done mostly in Europe and 30 other countries and imported into the US until recently, as it was illegal to cultivate hemp in the US until the 2014 Farm Bill.. Now many states have voted to make hemp cultivation legal for research and industrial production
So, Currently CBD from hemp plants are usually only 25 parts per million (so 25ppm vs. 150,000 ppm CBD from cannabis flowers).
While it seems like “cannabis beauty” is a sudden trend, it’s nothing new, with Eastern cultures including China using these effective ingredients for thousands of years. Hemp oil has trace levels of THC and is heavy in omega fatty acids, which are essential for moisturizing dull skin. Fatty acids in hemp oil also help regenerate the skin’s protective outer layer, leaving it smoother and younger looking. Cannabis creams cannot get you high. They aren’t designed to penetrate the skin or enter the bloodstream. Besides CBD, a cannabinoid, hemp oil contains vitamins C and E to help protect hair from broken or split ends and protect skin and hair against damage from the sun. They also keep free radicals from damaging collagen and elastin, which, as you know, gives skin its tight, youthful appearance. B complex vitamins found in hemp are part of the construction process of skin, hair, and nails. Vitamins A and D in hemp oil help with healthy looking skin, as they are responsible for skin repair. Additionally, vitamin A is widely accepted as important for skin cell growth, inhibiting oil production, and promoting skin cell differentiation
Let’s look at the difference between hemp and marijuana. There is still a lot of confusion about that.
Cannabinoids can come from medical marijuana plants or from industrially grown hemp plants. Both are varieties of Cannabis sativa but they are grown for different purposes, and each one comes with its own rapidly changing legal status at the Federal, state, and local level. Hemp was cultivated over the centuries for the strength of its fibers for clothing, food, oil, and most recently, biofuels. Marijuana was bred over the centuries for it’s mystical and spiritual qualities due to its psychoactive THC. In the US, hemp is defined as containing less than .3% THC and marijuana is defined as containing more than .3% THC. Most marijuana strains today contain about 20% THC and up to 35% for the prize blends
The following info comes from an article in “Hawaii, Health, and Medicine” in August 2017:
Complementary and Alternative Medicine (CAMO) on Oahu is currently educating Hawaii’s veterans on how to best cope with post-traumatic stress disorder (PTSD) with the help of medicinal cannabis.
Paring adaptive sports activities with medicinal cannabis, CAMO’s services provide disabled veterans and their families a sense of optimism and hope. Though focusing primarily on military veterans, CAMO rejects no one.
Based on the island of Oahu, CAMO provides a modern holistic approach to helping today’s veterans who struggle to overcome mental health issues. A common ailment, approximately eight million adults suffer from PTSD annually. According to the Department of Veterans Affairs:
Hawaii is just one of 23 states that currently lists post-traumatic stress disorder as a qualifying condition for medical marijuana. Here is a quick list of the states that currently allow medicinal cannabis (in some form) as a treatment for PTSD.
CAMO advocates “using legal oils from industrial hemp” as a holistic treatment for PTSD until real medical marijuana is available.
Oct 15, 2017 “The real story is the hypocrisy around medical marijuana,” Oz said as the Fox & Friends hosts appeared stunned. “People say marijuana is a gateway drug to narcotics; it may be the exit drug to get us out of the narcotic epidemic. We’re not allowed to study it because it’s a Schedule I drug,” Oz added. “And I personally believe it could help.”
This is from Marijuanas Stocks, http://marijuanastocks.com/colleges-universities-are-adding-marijuana-classes-to-their-curriculum/. I thought it was a very interesting article:
Throughout the United States, more and more universities are starting to offer marijuana stocks classes to students interesting in learning more about the plant. Marijuana has quickly emerged as a multi-billion dollar industry, with an advancing number of states looking to capitalize off of the green rush.
With so many people, looking to get in on the action, we are seeing a ton of new innovative products and companies surfacing, keeping the U.S. economy above water. So it all makes sense that as marijuana increasingly looks to saturate American life, it’s getting more representation in the world of academia.
Colleges and Universities across the United States are beginning to offer courses in the hope of investigating deeper into the legal and biological consequences of marijuana use. According to an article in Forbes, institutions such as Ohio State University, University of Vermont and the University of California, David are now offering a class on the it’s biology and use of marijuana as well as legal issues around it. Students have the ability to choose whether you want to earn credits towards their final degrees from these marijuana seminars or not.
At the University of Vermont, students can study Medical Marijuana at a graduate level, this is a program that focuses on Cannabis chemistry its effects and the emerging therapeutic uses, combined with the political and socioeconomic influences on marijuana laws.
“Educating people about the science of cannabis and the legal issues surrounding it allows people to enter the industry in a more legitimate way, equipped with real data and real knowledge, not myths,”” cannabis industry consultant Shannon Vetto states.
Currently, in the United States, there are two cannabis colleges, the THC University and the Cannabis Training University. Though the fact the traditional academic institutions are starting to recognize the value in R&D of cannabis shows the legitimacy of this booming industry.
|This was taken and shared from ” Cannabis Culture”:
Since the discovery of the endocannabinoid system (ECS) and various phytocannabinoids beyond just tetrahydrocannabinol (THC), it seems that a shift occurred in how we approach cannabis. According to some, Clinical Endocannabinoid Deficiency is actually an umbrella term for various conditions, in particular types of :
Essentially, a CECD means a lack of endocannabinoids. The solution? Phytocannabinoids, which are found in abundance in cannabis. To state simply, a lack of cannabinoids could explain in some cases why conditions like migraine, fibromyalgia and IBS arise, and why people suffering from these conditions might find cannabis to be therapeutic.
Now, there are a lot of conditions that could be linked to a CECD. This is perhaps because of the ECS’ intimate relationship with homeostasis (the balance of the body’s physiological processes), and there is still the chicken-or-egg question of these conditions arise because of a CECD, or does suffering from, say, multiple sclerosis or persistent headaches eventually cause a CECD? The answer is likely to be both, and it could be one of the key reasons why cannabis is so useful for so many conditions.
The CECD concept comes from Dr. Ethan Russo, who is a leading researcher on cannabidiol (CBD) and was involved in the development of GW Pharmaceutical’s Epidiolex, a CBD extract for epilepsy, and currently at Stage 3 development in the US. To see more of his work, check out the following links:
The original 2004 paper, which states:
Migraine, fibromyalgia, IBS and related conditions display common clinical, biochemical and pathophysiological patterns that suggest an underlying clinical endocannabinoid deficiency that may be suitably treated with cannabinoid medicines. However, the lack of evidence at the time made it just an educated guess based upon some observable data and experimentation.
As stated earlier, the evidence is mounting. Neurologist and Medical Scientist Ethan Russo is at the spearhead of this research. In this video he explains the concept of CECD and the importance of CBD. In 2016 Ethan Russo updated his findings in a peer reviewed journal that can be found here.
The abstract to Russo’s article states:
Currently, however, statistically significant differences in cerebrospinal fluid anandamide levels have been documented in migraines, and advanced imaging studies have demonstrated ECS hypofunction in post-traumatic stress disorder. Additional studies have provided a firmer foundation for the theory, while clinical data have also produced evidence for decreased pain, improved sleep, and other benefits to cannabinoid treatment and adjunctive lifestyle approaches affecting the ECS.
We all know how much clout the NFL, NBA, and sports figures have to influence public mores.
As medical marijuana becomes legal in more states, professional sports leagues will have to at least look into their drug policies banning its use. The NFL reportedly plans to study marijuana’s effectiveness as an option for pain management, and whether it is a safer alternative to prescription pain medicines for the future.
NBA commissioner Adam Silver, who has been against opening up the NBA’s drug policy with regards to marijuana in the past, sounded more open to looking into its effectiveness and potential usefulness for pain management, as the NFL is reportedly doing, and having discussions about that with the Players’ Association.
from article by Robby Kalland on Uproxx.com